A medical AI company approached Excelra to curate clinical trial outcome data to augment their platform and improve clinical trial predictions. Excelra delivered over 23,000 data points from over 1,600 clinical trials within 4 weeks. This saved the AI company's data scientists 170 hours and allowed them to focus on data interpretation rather than data mining. The high-quality data curated by Excelra integrated seamlessly into the AI company's platform and workflows.

1. Quality Clinical Trial
Outcomes Data in 4 weeks
Delivering 99.9%
Trial by Fire:
How Excelra augmented
predictions for a Medical
AI company
Case study

2. EXCELRA |1
Stumbling blocks of data mining
Performing high-quality systematic literature reviews
poses multiple mixes. A few are access to the right
expertise, coping with regulatory requirements, and
leveraging different systematic literature review tools &
techniques. Doing all the tasks in less time but highest
relevancy is a challenge
A large global biomedical intelligence company
approached Excelra. Their 'technology insights' team
aimed to leverage curated quality data from the various
research works of literature to augment their knowledge
platforms and upgrade clinical trial-related information.
Their Artificial Intelligence (AI) and Machine Learning
(ML) - based platform, on real-time ingests quality
Clinical Trials Outcome Data (CTOD), custom curated by
Excelra. The platform then accurately predicts clinical
trial success; performs retrospective analysis and other
clinical trial program improvement opportunities.
170
Highlights:
Hours of data
scientists saved
99.9%
High quality
data curated
4 Weeks
Tight timelines met
~23,000
Reliable data points
delivered
>1600
Clinical trials
studies mined

3. EXCELRA |2
Power of simple solutions
A paradigm shift in patient care and drug development means having the most
comprehensive dataset of scientific outcomes from clinical trial data. The
company approached Excelra to achieve the mission of bringing efficiency to
clinical trial success predictions. In the backdrop of the pandemic, with stringent
timelines, the company needed to get clinical insights quickly, at optimal quality,
and in an analytics-ready format. The company's objective was to focus on
interpreting the clinical data & predictive decisions based on Excelra's accurate
and real-time research data & insights
Designing screening models for custom file formats to predict
Pharma trial success in 5 Therapeutic areas- Oncology,
Immunology, Infections, Metabolic & Respiratory
We are a biomedical data intelligence company
supporting and improving decision making in precision
medicine for healthcare organizations. Our technology
leverages unique, high-quality, cleaned, and curated
data. Excelra is doing a fantastic job in curating and
validating clinical trial outcome data with a meticulous
approach to finding and assessing relevant sources.
SVP, Global Head of Pharma & Biotech

4. Excelra's Clinical Trial Outcome Data (CTOD) solutions offered the company an
efficient turnaround and custom-curated data sets. Excelra scientists and
research data teams specialize in creating clinical trial-specific and drug-specific
summary-level data. The data arrangement follows Excelra's model best
practices of accurately curating trial design, demographics, treatment, clinical
end-point patterns, and many others from the source data. The solution caters to
custom requests more often, as with this biomedical intelligence company, but
applies the industry gold-standard evidence-based practice known as the
Patient, Intervention, Comparison, Outcome, and Study design and type model
(PICOS). The framework has seen successful results across Excelra's
engagements. The extent of historical data that one must go per indication,
knowledge translation, and volumes makes custom-curation demanding
Where the rubber meets the road
Excelra’s Clinical Trial Outcome Data (CTOD) in analysis-ready
consumable format to predict clinical trial success rates
EXCELRA |3

5. Finding the right set of data from a
massive amount of available clinical trial
information
Adding scientific value to disease specific trials
and enhancing inclusion / exclusion criteria
Assembling systematic curated data into
formats that aidpredictive analysis
The gold standard framework needed to succeed in any
literature reviews are the 3 Ps: Protocol, PICOS and PRISMA.
Excelra adds the 4th element: Its People Scientists
EXCELRA |4
Excelra solution
01
02
03
04

6. Championing high quality, clean, reliable data
EXCELRA |5
The solution experts focused on
different search & discovery
possibilities, fetching and deriving
scientifically relevant data with
supreme quality and detailed
insights. The company successfully
applied artificial intelligence and
proprietary analytics over the highly
accurate curated data provided
by Excelra. Data delivery was in the
analytics-ready format as
co-created with the company. The
curated data worked seamlessly
with their platform & workflows
without any additional effort or IT
involvement.
The company's research team
benefitted from the reduced data
mining turnaround time. Most
importantly, the research team
reduced their cognitive overload to
focus on their core competency of
data interpretation. Thus, Excelra
enabled the research team to achieve
data-driven decision-making for drug
development and healthcare
outcomes. The relationship began with
just one project. However, given the
outcomes and the value add Excelra
provides, the company decided to
extend our partnership and has been
with us for many years now.

7. For more information write to us on: marketing@excelra.com
Excelra's data and analytics solutions empower innovation in life sciences across the value chain from
discovery to market. The Excelra Edge comes from a seamless amalgamation of proprietary curated data
assets, deep domain expertise and data science. The company's multifaceted teams harmonize and
analyse large volumes of disparate unstructured data using cutting-edge technologies. We galvanize
data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development.
Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global
clients, including 15 of the top 20 large Pharma.
marketing@excelra.com
UTRECHT
www.excelra.com
Data Science to Empower
Life Science Innovation
HYDERABAD BOSTON